Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial AE Giuliano, KK Hunt, KV Ballman, PD Beitsch, PW Whitworth, ... Jama 305 (6), 569-575, 2011 | 3576 | 2011 |
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy HM Kuerer, LA Newman, TL Smith, FC Ames, KK Hunt, K Dhingra, ... Journal of Clinical Oncology 17 (2), 460-460, 1999 | 1546 | 1999 |
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial JC Boughey, VJ Suman, EA Mittendorf, GM Ahrendt, LG Wilke, B Taback, ... Jama 310 (14), 1455-1461, 2013 | 1518 | 2013 |
Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 … AE Giuliano, KV Ballman, L McCall, PD Beitsch, MB Brennan, ... Jama 318 (10), 918-926, 2017 | 1510 | 2017 |
Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of … AE Giuliano, L McCall, P Beitsch, PW Whitworth, P Blumencranz, ... Annals of surgery 252 (3), 426-433, 2010 | 1492 | 2010 |
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in … AU Buzdar, NK Ibrahim, D Francis, DJ Booser, ES Thomas, RL Theriault, ... Journal of clinical oncology 23 (16), 3676-3685, 2005 | 1487 | 2005 |
Whole-genome analysis informs breast cancer response to aromatase inhibition MJ Ellis, L Ding, D Shen, J Luo, VJ Suman, JW Wallis, BA Van Tine, ... Nature 486 (7403), 353-360, 2012 | 1194 | 2012 |
Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons … A Lucci, LM McCall, PD Beitsch, PW Whitworth, DS Reintgen, ... Journal of Clinical Oncology 25 (24), 3657-3663, 2007 | 964 | 2007 |
Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted … AS Caudle, WT Yang, S Krishnamurthy, EA Mittendorf, DM Black, ... Journal of Clinical Oncology 34 (10), 1072, 2016 | 806 | 2016 |
Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial LG Wilke, LM McCall, KE Posther, PW Whitworth, DS Reintgen, AM Leitch, ... Annals of surgical oncology 13, 491-500, 2006 | 685 | 2006 |
Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor–rich stage 2 to 3 breast cancer … MJ Ellis, VJ Suman, J Hoog, L Lin, J Snider, A Prat, JS Parker, J Luo, ... Journal of clinical oncology 29 (17), 2342, 2011 | 647 | 2011 |
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer C Hatzis, L Pusztai, V Valero, DJ Booser, L Esserman, A Lluch, T Vidaurre, ... Jama 305 (18), 1873-1881, 2011 | 640 | 2011 |
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor … AU Buzdar, V Valero, NK Ibrahim, D Francis, KR Broglio, RL Theriault, ... Clinical Cancer Research 13 (1), 228-233, 2007 | 596 | 2007 |
Long-term prognostic risk after neoadjuvant chemotherapy associated with residual cancer burden and breast cancer subtype WF Symmans, C Wei, R Gould, X Yu, Y Zhang, M Liu, A Walls, ... Journal of Clinical Oncology 35 (10), 1049, 2017 | 595 | 2017 |
Primary treatment of cystosarcoma phyllodes of the breast AW Chaney, A Pollack, MD Mcneese, GK Zagars, PWT Pisters, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2000 | 555 | 2000 |
Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the … AE Giuliano, K Ballman, L McCall, P Beitsch, PW Whitworth, ... Annals of surgery 264 (3), 413-420, 2016 | 553 | 2016 |
Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer Y Xing, M Foy, DD Cox, HM Kuerer, KK Hunt, JN Cormier Journal of British Surgery 93 (5), 539-546, 2006 | 508 | 2006 |
Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks MC Green, AU Buzdar, T Smith, NK Ibrahim, V Valero, MF Rosales, ... Journal of Clinical Oncology 23 (25), 5983-5992, 2005 | 508 | 2005 |
Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience AM Chen, F Meric-Bernstam, KK Hunt, HD Thames, MJ Oswald, ... Journal of Clinical Oncology 22 (12), 2303-2312, 2004 | 479 | 2004 |
Sentinel-lymph-node biopsy for breast cancer—not yet the standard of care KM McMasters, AE Giuliano, MI Ross, DS Reintgen, KK Hunt, DR Byrd, ... New England Journal of Medicine 339 (14), 990-995, 1998 | 470 | 1998 |